Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Nutriband Inc

NTRB ✓ COMPLIANT ☆ Track — members

NASDAQ · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: BUY

Last Close

$6.96

▲ +14.47%

Market Cap $84.60M · Vol 23.64K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$84.60M

Micro Cap

Div Yield

N/A

Dividend with no set frequency

EPS Growth

N/A

YoY

RSI (14)

74.13

Momentum

Beta

2.08

vs Market

52W High

$8.54

18.50% below

52W Low

$2.80

148.57% above

Volume

23.64K

Avg 7.91K

P/B

8.72

Price-to-book

ROE

N/A

Return on equity

Free Float

43.18%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Nutriband Inc (NTRB) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NTRB pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+23.62%

+114.15%

+102.92%

+74.44%

YTD

+53.30%

+0.43%

+171.88%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$2.04M
Net Income	$-8,229,630.00
Revenue Growth (YoY)	-29.71%
Gross Margin	27.81%
Operating Margin	-408.41%
Net Profit Margin	-404.08%
ROE	N/A
ROA · ROIC	-109.60% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	27.38
P/B	8.72
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	12.16M

Technical Indicators

50-Day SMA	$3.72
200-Day SMA	$3.99
RSI (14)	74.13
Beta	2.08
52-Week High	$8.54
52-Week Low	$2.80

Volume Today	23.64K
Avg Daily Volume (30D)	7.91K
Relative Volume	2.99x
Volatility (10D)	112.24
Volatility (30D)	100.64
Free Float	43.18%

Analyst Consensus

BUY

Current Price $6.96

Mean Target $15.00

52W Low$2.80 52W High$8.54

Current

Target

$2.80 $8.54

Current Analyst target

+115.52% upside potential · 0 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG00GSMQF67

ISINUS67092M2089

CountryUSA

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -1.36% MDT Medtronic PLC -0.72% COR Cencora, Inc. +0.19% 7741.T HOYA CORPORATION -1.92% BDX Becton Dickinson and Co +0.81%

Company Profile

Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.